Listed by the USPTO as ALLEN, MARIANNE P
Tech Center 1600 • Art Units: 1647 1654 1672
This examiner grants 60% of resolved cases
ALLEN, MARIANNE P is assigned to Tech Center 1600 and Art Unit 1647. The profile records 1009 resolved cases, a 60.1% allowance rate, and an 18.4% interview lift. Median time to allowance is 1058 days. The substantial record supports using these figures as a meaningful guide to prosecution expectations, while the interview effect is more limited than the overall allowance outcome.
Top companies include Amgen Inc., Horizon Therapeutics Ireland Dac, and Genentech Inc. The leading firms are Casimir Jones, S.C., COOLEY LLP, and Riverside Law LLP. Counsel handling biotechnology matters can use these recurring participants to identify relevant experience with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17767620 | MODULATING INTERLEUKIN-10 SIGNALING TO BOOST HEALING IN DIABETIC WOUNDS | Non-Final OA | Rush University Medical Center |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy60.1% of resolved applications examined by Marianne P Allen were allowed (1,009 resolved cases), compared with 39.7% across Art Unit 1647 over the last five years.
This examiner's interview lift is +18.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Marianne P Allen took 1,058 days on average from filing to allowance.
Marianne P Allen examines applications in Art Unit 1647 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
